DALLAH HEALTHCARE COMPANY |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 165.4 SAR | -0.48% |
|
-3.50% | -3.73% |
| Mar. 20 | Dallah Healthcare Company Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Mar. 14 | Dallah Healthcare Logs Higher FY23 Net Profit, Revenue | MT |
| Sales 2024 * | 3.23B 860M | Sales 2025 * | 3.58B 956M | Capitalization | 16.16B 4.31B |
|---|---|---|---|---|---|
| Net income 2024 * | 426M 114M | Net income 2025 * | 505M 135M | EV / Sales 2024 * | 5.53 x |
| Net Debt 2024 * | 1.67B 445M | Net Debt 2025 * | 1.67B 446M | EV / Sales 2025 * | 4.98 x |
| P/E ratio 2024 * |
41.8
x | P/E ratio 2025 * |
31.2
x | Employees | - |
| Yield 2024 * |
1.4% | Yield 2025 * |
1.82% | Free-Float | 41.94% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | -0.48% | ||
| 1 week | -3.50% | ||
| Current month | -1.19% | ||
| 1 month | -7.91% | ||
| 3 months | -2.13% | ||
| 6 months | +18.14% | ||
| Current year | -3.73% |
1 week
163.00
173.80
1 month
163.00182.00
Current year
161.20194.00
1 year
131.40194.00
3 years
61.50194.00
5 years
34.75194.00
10 years
32.45194.00
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 67 | 08-03-28 | |
Salah Al-Faqih
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Chief Operating Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Talal Al-Maiman
BRD | Director/Board Member | - | - |
Tarek Al-Kasabi
CHM | Chairman | 72 | 93-12-31 |
Mohialdeen Kamel
BRD | Director/Board Member | 43 | 16-10-20 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.03% | 0 M€ | 0.00% | - | |
| 0.02% | 117 M€ | +0.68% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-24 | 165.4 | -0.48% | 48,674 |
| 24-04-23 | 166.2 | -1.19% | 72,665 |
| 24-04-22 | 168.2 | -0.83% | 80,306 |
| 24-04-21 | 169.6 | -0.12% | 49,509 |
| 24-04-18 | 169.8 | +1.07% | 144,233 |
End-of-day quote Saudi Arabian S.E., April 23, 2024
More quotes
Dallah Healthcare Company SJSC, formerly Dallah Healthcare Co, is a Saudi Arabia-based company engaged in the provision and operation of healthcare programs and utilities. The Company operates in the following business segments: Hospitals; Medicines, and Head Office. The Hospitalsâ segment objectives are to own, manage, operate and maintain healthcare facilities. The Medicinesâ segment objectives are to import, distribute, wholesale and retail medicines, as well as manufacture medicines, pharmaceuticals, herbals, health, cosmetics, detergents, disinfectants, and packaging materials. The Head Officeâs segment objectives are to operate, manage and maintain healthcare facilities; wholesale and retail surgical equipment, artificial parts, handicapped and hospitals equipment, as well as other supporting services.
Calendar
2024-04-28
- Q1 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
10
Last Close Price
165.4
SAR
Average target price
154.4
SAR
Spread / Average Target
-6.66%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -3.73% | 4.33B | |
| -24.40% | 15.55B | |
| +1.80% | 12.05B | |
| +2.82% | 11.5B | |
| +10.15% | 10.69B | |
| +24.10% | 8.26B | |
| -0.40% | 7.79B | |
| +22.90% | 7.31B | |
| +5.73% | 6.75B | |
| +50.39% | 4.51B |
- Stock Market
- Equities
- 4004 Stock
